Orbitofrontal cortex-hippocampus potentiation mediates relief for depression: A randomized double-blind trial and TMS-EEG study

It has been 15 years since repetitive transcranial magnetic stimulation (rTMS) targeting the dorsolateral prefrontal cortex (DLPFC) was approved by the FDA for clinical depression treatment. Yet, the underlying mechanisms for rTMS-induced depression relief are not fully elucidated. This study analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sizhu, Li, Xing-Xing, Wei, Shuochi, Zhao, Di, Ding, Jinjun, Xu, Yongming, Yu, Chang, Chen, Zan, Zhou, Dong-Sheng, Yuan, Ti-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313932/
https://www.ncbi.nlm.nih.gov/pubmed/37263267
http://dx.doi.org/10.1016/j.xcrm.2023.101060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313932/
https://www.ncbi.nlm.nih.gov/pubmed/37263267
http://dx.doi.org/10.1016/j.xcrm.2023.101060

Ejemplares similares